HealthcareRezolute rises as FDA lifts clinical hold on hyperinsulinism therapyBy Helitra.com·September 10, 2024·1 min read Rezolute rises as FDA lifts clinical hold on hyperinsulinism therapy Source: SeekingalphaADVERTISEMENT ADVERTISEMENTClinical FDA hold hyperinsulinism lifts Rezolute rises therapy Post navigation Previous storyEvaxion reports positive mid-stage trial data on lead cancer vaccine candidate EVX-01Next storyAutonomix rises after it reports reduction of pain in pancreatic cancer treatment
Fitness · HealthcareHydroxyapatite toothpaste promises to better protect your teeth. Here’s what the science says.November 7, 2026There’s a new kid on the block in the toothpaste aisle. Next to the usual fluoride formulas, another option has been appearing: hydroxyapatite…
Fitness · HealthcareYour Go-To Drink for UTI Prevention May Have Yet Another Surprising Health PerkNovember 6, 2026“Hearst Magazines and Yahoo may earn commission or revenue on some items through these links.” Cranberry juice is known in certain circles as…
Fitness · HealthcareScientists identify daily step count linked to better cognitive performanceNovember 6, 2026The number of steps you walk each day could have a notable impact on your brain health, researchers have found. Experts at the…